What is the treatment for Yersinia infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Yersinia Pestis Infection

Dual antimicrobial therapy with a fluoroquinolone (ciprofloxacin, levofloxacin, or moxifloxacin) plus an aminoglycoside (gentamicin or streptomycin) for 10-14 days is the most effective treatment for Yersinia pestis infection, significantly reducing mortality across all clinical forms of plague. 1

First-Line Treatment Options

For Severe Pneumonic or Septicemic Plague:

  • Dual therapy with two distinct classes of antimicrobials is required:

    • Fluoroquinolones:
      • Ciprofloxacin: 400 mg every 8 hrs IV or 750 mg every 12 hrs PO
      • Levofloxacin: 750 mg every 24 hrs IV or PO
      • Moxifloxacin: 400 mg every 24 hrs IV or PO

    PLUS

    • Aminoglycosides:
      • Gentamicin: 5 mg/kg every 24 hrs IV or IM
      • Streptomycin: 15 mg/kg every 12 hrs IM (maximum 1 g/dose) 2, 1

For Uncomplicated Bubonic Plague:

  • Monotherapy may be sufficient with:
    • Streptomycin: 15 mg/kg every 12 hrs IM (maximum 1 g/dose)
    • Doxycycline: 200 mg loading dose, then 100 mg every 12 hrs PO 1, 3

Treatment Duration

  • Continue treatment for 10-14 days or until patient is afebrile for at least 48 hours 2, 1

Special Populations

Children:

  • Same first-line agents as adults with adjusted dosing:
    • For children <45 kg: Ciprofloxacin 15 mg/kg every 12 hrs IV or IM (maximum 1g/dose)
    • Doxycycline dosing: Body weight <45 kg: 4.4 mg/kg loading dose, then 2.2 mg/kg every 12 hrs IV or PO 2
  • Note: Doxycycline should only be used in children <8 years when other options are unavailable due to dental staining risk 1

Pregnant Women:

  • Fluoroquinolones remain first-line despite pregnancy
  • Gentamicin is an acceptable alternative but requires monitoring 1
  • Dual therapy recommended with distinct classes of antimicrobials 2

Post-Exposure Prophylaxis

  • Recommended for individuals exposed to Y. pestis:
    • Ciprofloxacin: 500 mg every 8 hrs PO or 750 mg every 12 hrs PO
    • Levofloxacin: 750 mg every 24 hrs PO
    • Doxycycline: 100 mg every 12 hrs PO
  • Duration: 7 days 2, 1

Infection Control Measures

  • Patients with bubonic plague should be kept in respiratory isolation for the first 48 hours of effective treatment
  • Patients with pneumonic plague require strict respiratory isolation for 48 hours after starting effective therapy 1

Treatment Efficacy and Monitoring

  • Early treatment is crucial - mortality decreases from 50% untreated to 5-10% with appropriate therapy
  • Survival rates with appropriate treatment:
    • Aminoglycosides: 83-91% survival
    • Tetracyclines: 95-98% survival
    • Fluoroquinolones: 100% survival (limited data) 1
  • Monitor for clinical improvement within 24-48 hours
  • Check aminoglycoside levels as indicated
  • Adjust therapy based on culture and sensitivity results when available 1

Important Caveats

  • Beta-lactam antibiotics should be avoided due to potential poor efficacy and accelerated mortality 1
  • Intracellular Y. pestis may be less susceptible to certain antibiotics like gentamicin or doxycycline, while streptomycin and ciprofloxacin maintain similar efficacy against both intracellular and extracellular bacteria 4
  • Common treatment pitfalls include delayed treatment initiation, inappropriate monotherapy in severe cases, inadequate treatment duration, and improper isolation 1
  • In bioterrorism scenarios, consider the possibility of engineered resistance and adjust therapy accordingly 1

References

Guideline

Treatment of Yersinia Pestis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.